China-based GPs Sinopharm Capital and Cedarlake Capital have announced a $20 million investment in Singapore-based healthcare platform Novena Global Lifecare, along with a strategic partnership for a $150 million fund that will support Southeast Asian healthcare companies.
The new vehicle, the Sino-Singapore Healthcare Fund, will back companies involved in medical services, biomedical projects, mature drugs, and precision medicine. Investees are expected to benefit from...
Indonesia’s Kejora Ventures and Korea’s InterVest have jointly led a $30 million Series B investment in Malaysian drone technology supplier Aerodyne.
Tencent Holdings, JS Capital, Tiger Global Management, and Prime Venture Partners have provided a $56 million Series B round to India’s MyGate, a security app for gated communities.
Ansun BioPharma, a US-based drug developer led by a former executive at healthcare-focused VC firms Caduceus Asia Partners and OrbiMed, has raised $80 million in Series B funding from a predominantly Chinese investor base.
US-based mid-market buyout firm Cornell Capital has made its first investment in Asia with a commitment to Taiwan-headquartered cable manufacturer Lorom Holding.